23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial
暂无分享,去创建一个
S. Senan | A. Louie | G. Rodrigues | D. Palma | S. Gaede | G. Zaric | Mitchell C C Liu | A. Warner | R. Olson | A. John-Baptiste | N. Kopek | A. Swaminath | S. Harrow | L. Mulroy | D. Schellenberg | S. Senthi | Yujie Chen | M. Qu